USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:20 PM 2012

NYSE 8095.28 12.30 Index Moved Up

NASDAQ 2927.03 11.17 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and USNA...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

USANA Health Sciences Inc. Com

Volatility

Matrix

Run Correlation

Diversification

Average diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and USANA Health Sciences Inc. Com in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.14

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Suggest

48.9

Intraday

One Month

^(0.32)

0.65%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.892B	Volume	147120
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.65%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.32
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

Illumina's Board Unanimously Rejects Roche's Offer; Shire Announces FDA ...

BioMedReports (subscription) - Feb 8, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

2012-02-07

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ...

MarketWatch (press release) - Feb 7, 2012

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals Announces FDA Priority Review Designation for Crofelemer NDA
- NCTechNews (press release)

2012-02-07

Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For Crofelemer NDA For Treatment Of Diarrhea

Reuters Key Development - Feb 7, 2012

2012-02-07

Salix Pharmaceuticals Crosses Above its 10-day MA (SLXP)

Financial News Network Online - Jan 31, 2012

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

2012-01-31

Salix Scores with Oral Relistor

2011-12-27

Salix Pharmaceuticals (SLXP): Zacks Rank Buy

2011-12-19

Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy

2011-11-28

37.49

Intraday

One Month

^0.49

1.32%

USNA

NYSE

USANA Health Sciences Inc. Com

P/E	11.79	P/B Ratio	3.48
Open	37.00	Day Low	36.41
Market Cap	560.8M	Volume	106973
Last Close	37.00	Short Ratio	33.90
Last Traded	2/9/2012	Year High	38.50
Percent Change	1.32%	EBITDA	84.0M
Year Low	23.10	Absolute Change	0.49
Book Value	10.642	EPS	3.137
PEG Ratio	0.59	Day High	37.70
Target Price	38.20	Current EPS	3.137
This Year EPS	3.48	Next Year EPS	4.02
Current PE	11.79	This Year PE	10.63
Next Year PE	9.20	Dividend	Not Applicable

USANA Health Sciences Announces Fourth Quarter and Full-Year 2011 Financial ...

Business Wire (press release) - Feb 8, 2012

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full year ended December 31, 2011.

2012-02-08

USANA Health Sciences, Inc. Issues FY 2012 Guidance; EPS Guidance Below Analysts' Estimates

Reuters Key Development - Feb 7, 2012

2012-02-07

7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows

Seeking Alpha - Feb 4, 2012

Interested in finding stocks that may be trading below their fair value? If so, here are some ideas to get started on your search.

2012-02-03

7 Undervalued Stocks Reporting Earnings Next Week With Strong Hedge Fund Buying

Seeking Alpha - Feb 1, 2012

We're now in the middle of earnings season and many companies have yet to post their fourth-quarter results. Next week alone over 500 companies are reporting their earnings.

2012-02-01

Zacks Releases Four Powerful ''Buy'' Stocks: USANA Health Sciences, Williams-Sonoma, Silicon Motion Technology and CenturyLink

2011-12-07

USANA Health Sciences (USNA): Zacks Rank Buy

2011-12-07

Bullish MACD for USNA

2011-07-06